Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes (Q36428062)

14 August 2017

Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes (English)

1 reference

14 August 2017

1 reference

Miyako Kishimoto

1

1 reference

14 August 2017

Mitsuhiko Noda

series ordinal

2

1 reference

14 August 2017

28 September 2012

1 reference

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

1

1 reference

14 August 2017

11

1 reference

Creative Commons Attribution 2.0 Generic

14 August 2017

start time

28 September 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

The Physiology of Glucagon-like Peptide 1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

The role of gut hormones in glucose homeostasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Incretins and the development of type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Reproducibility of glucose measurements using the glucose sensor.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

28 June 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508109

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

21 September 2018

1 reference

https://api.crossref.org/works/10.1007/S13300-012-0011-X

Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055336

12 December 2020

inferred from PubMed ID database lookup

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055336

12 December 2020

inferred from PubMed ID database lookup

Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055336

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S13300-012-0011-X

1 reference

release_ufyc533r3rhbfnxm6oaztzm2ra

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ufyc533r3rhbfnxm6oaztzm2ra

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

23055336

1 reference